 |
|
 |
Eumovate Eczema/Dermatitis Cream 15g |
|
Clobetasone butyrate 0.05 % w/w
Cream
Eumovate Eczema and Dermatitis Cream is suitable for the short-term treatment and control of patches of eczema and dermatitis including atopic eczema and primary irritant and allergic dermatitis.
|
|
Eumovate Eczema and Dermatitis Cream is suitable for use in adults and children aged 12 years or older.
Use in children under 12 years only on the advice of a doctor.
Eumovate Eczema and Dermatitis Cream should be applied sparingly (see section 6.6 Instructions for Use/Handling) to the affected area twice a day for up to 7 days. If the condition resolves within 7 days, treatment with Eumovate Eczema and Dermatitis Cream should be stopped. If the condition does not improve in the first 7 days or becomes worse the consumer will be advised to see a doctor. If after 7 days of treatment improvement is seen but further treatment is required, the consumer will be advised to see a doctor.
|
|
Hypersensitivity to Eumovate Eczema and Dermatitis Cream or any of its ingredients.
Broken skin or skin lesions caused by infection with viruses (e.g. herpes simplex, chickenpox), fungi (e.g. candidiasis, tinea) or bacteria (e.g. impetigo).
Acne vulgaris.
|
|
As with all topical corticosteroids absorption can be increased by the use of occlusion, which in infants and children can lead to adrenal suppression. In addition, the management of eczema and dermatitis in infants and young children requires the supervision of a physician. Self-management is therefore limited to adults and children aged 12 and over and for no more than 7 days continuous treatment without occlusion.
Consumers will be advised not to initiate treatment of the same site for a third time without seeking medical advice to confirm the diagnosis.
Consumers should be advised to use Eumovate Eczema and Dermatitis Cream only for the treatment of eczema or dermatitis, as it may mask or exacerbate other conditions. In particular, consumers will be advised not to use Eumovate Eczema and Dermatitis Cream on the groins, genitals or between the toes as these are common sites of fungal infections.
Eumovate Eczema & Dermatitis Cream should not be used on the face as it may cause acneform pustules or perioral dermatitis.
Medical advice should be sought in seborrhoeic dermatitis since this involves areas of skin where Eumovate Eczema and Dermatitis Cream should not be used.
Consumers should be warned against letting the cream get into the eye, as topical steroids can cause glaucoma.
Consumers should be warned not to use other topical corticosteroids, either prescribed or obtained over-the-counter (such as hydrocortisone), at the same time as Eumovate Eczema and Dermatitis Cream as this may increase the risk of unwanted effects.
Consumers should be advised that they should not use topical clobetasone for the treatment of psoriasis as rebound exacerbation may be a problem. This condition should be managed under the care of a physician
|
|
 |